Nab-paclitaxel and Gemcitabine Hydrochloride Followed by Radiation Therapy Before Surgery in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Gemcitabine
Related studies linked through entity extraction aliases.
Nab-pacliatxel Plus Gemcitabine in Korean Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of Dexanabinol in Combination With Chemotherapy in Patients With Advanced Tumours
- Status
- UNKNOWN
- Phase
- PHASE1
MK-3475 and Gemcitabine in Non-Small Cell Lung Cancer (NSCLC)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111)
- Status
- TERMINATED
- Phase
- PHASE3
A Study of Atezolizumab (MPDL3280A) Compared With a Platinum Agent (Cisplatin or Carboplatin) + (Pemetrexed or Gemcitabine) in Participants With Stage IV Non-Squamous or Squamous Non-Small Cell Lung Cancer (NSCLC) [IMpower110]
- Status
- COMPLETED
- Phase
- PHASE3
Ph2 Nab-paclitaxel With Gemcitabine to Determine Efficacy in Advanced Non-squamous NSCLC.
- Status
- WITHDRAWN
- Phase
- PHASE2
Immunotherapy and SBRT Study in Borderline Resectable Pancreatic Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Phase 2 Study of MM-141 Plus Nab-paclitaxel and Gemcitabine in Front-line Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Nimotuzumab Combinated With Gemcitabine in K-RAS Wild-type Locally Advanced and Metastatic Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Open-Label, Dose-Escalation Study of Pemigatinib in Subjects With Advanced Malignancies - (FIGHT-101)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Safety Study of SEA-CD40 in Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE1
Study of DKN-01 and Gemcitabine/Cisplatin in Patients With Carcinoma to Primary to the Intra- or Extra-Hepatic Biliary System or Gallbladder
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage
- Status
- TERMINATED
- Phase
- PHASE3
Italian Multicenter Study Comparing FOLFOXIRI Versus Gemcitabine as Adjuvant Treatment for Resected Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
A Global Study to Assess the Effects of MEDI4736 (Durvalumab), Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE3
First-line Metastatic Pancreatic Cancer : FOLFIRINOX +/- LV5FU2 in Maintenance Versus Firgem
- Status
- COMPLETED
- Phase
- PHASE2